Katherine Blackburn Watson, FNP-BC | |
888 Bestgate Rd, Annapolis, MD 21401-3091 | |
(443) 949-3401 | |
Not Available |
Full Name | Katherine Blackburn Watson |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 888 Bestgate Rd, Annapolis, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487429726 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | NP1053126 (District Of Columbia) | Primary |
Entity Name | St Paul Place Specialists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871549196 PECOS PAC ID: 7719882943 Enrollment ID: O20031202000084 |
News Archive
On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University's Biodesign Institute.
In a paper published in The Official Journal of the International Purine Club University of Liverpool researchers have successfully identified how certain genes can contribute towards a person's susceptibility to stress fracture injuries. This research provides a platform for further research into providing a personalised health approach to this common sports injury.
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Cancer treatment continues to improve for many types of cancer, leading to increased life expectancy for many survivors.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Katherine Blackburn Watson, FNP-BC 215 15th St Se, Washington, DC 20003-2335 Ph: (770) 639-2599 | Katherine Blackburn Watson, FNP-BC 888 Bestgate Rd, Annapolis, MD 21401-3091 Ph: (443) 949-3401 |
News Archive
On July 8, at approximately 11:26 a.m. EDT, the space shuttle Atlantis will streak skyward from the Kennedy Space Center's launch pad 39A, for one last mission. While the STS-135 flight marks the end of the space shuttle's glory days, its final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Dr's. Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University's Biodesign Institute.
In a paper published in The Official Journal of the International Purine Club University of Liverpool researchers have successfully identified how certain genes can contribute towards a person's susceptibility to stress fracture injuries. This research provides a platform for further research into providing a personalised health approach to this common sports injury.
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Cancer treatment continues to improve for many types of cancer, leading to increased life expectancy for many survivors.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
› Verified 4 days ago
Brenda Kay Mathews-vitello, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Defense Hwy, Suite 400, Annapolis, MD 21401 Phone: 410-897-9841 Fax: 410-897-9852 | |
Mrs. Jillian Lynn Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 101, Annapolis, MD 21401 Phone: 877-461-1564 | |
Alexa Lee St Laurent, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-224-7007 | |
Dabney Lipscomb, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Wayson Pavilion, Suite 150, Annapolis, MD 21401 Phone: 443-481-1199 Fax: 443-481-1495 | |
Ms. Stephanie Zwonitzer, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1750 | |
Mrs. Hollis Stewart Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 678 Genessee St, Annapolis, MD 21401 Phone: 412-508-7896 | |
Lisa Kristine Butler, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy Ste 670, Annapolis, MD 21401 Phone: 443-481-1150 |